Methylene Blue: Clinical Trials

95 trials of Methylene Blue, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

58 completed, 18 unknown, 5 not yet recruiting, 5 recruiting. 30 Phase 2, 29 Not applicable, 13 Phase 3, 10 Phase 1, 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 230Completed 18, Unknown 4, Not yet recruiting 3, Recruiting 3, Terminated 1, Withdrawn 1
Not applicable29Completed 21, Unknown 6, Terminated 1, Withdrawn 1
Phase 313Completed 7, Unknown 3, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1
Phase 110Completed 5, Recruiting 2, Unknown 2, Terminated 1
Phase 48Completed 5, Not yet recruiting 1, Terminated 1, Unknown 1
Early Phase 15Unknown 2, Active not recruiting 1, Completed 1, Not yet recruiting 1

Follow Methylene Blue: new trials by email Literature Review of Methylene Blue trials Research Report on Methylene Blue

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses
Standard of care breast abscess drainage, Methylene Blue, Lipid Emulsion - Breast Abscess
Phase 2Not yet recruitingUniversity of Rochester502027-07-012026-08-19
Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses
Methylene Blue, Lipid Emulsion, Insertion of optical fiber - Abscess
Phase 2Not yet recruitingUniversity of Rochester1202026-07-152026-02-10
Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection
Methylene Blue, Blue Light Illumination - Burns, Wound Infection
Early Phase 1Not yet recruitingUniversity of Oklahoma502026-06-012026-05-19
Methylene Blue in Total Knee Arthroplasty (TKA)
Methylene Blue 10 MG/ML (intra-articular application), Revision Arthroplasty for PJI (DAIR), Primary Total Knee Arthroplasty - Total Knee Arthroplasty, Prosthetic-joint Infection
Phase 1RecruitingUniversity of Miami202026-02-042026-04-14
Early Methylene Blue in the Microhemodynamics of Septic Patients
Methylene blue infusion - Septic Shock, Hypoperfusion
Phase 2 / Phase 3RecruitingCentro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva502026-01-092026-03-27
Local Methylene Blue Injection for Prevention of Anastomotic Leakage and Permanent Stoma After Low Anterior Resection for Rectal Cancer
methylene blue injection - Rectal Cancers
Phase 2RecruitingPeking University Cancer Hospital & Institute262025-11-252026-09-22
Methylene Blue Treatment of Chronic Hepatitis B Virus Infection
Methylene Blue - Chronic HBV Infection
Phase 2RecruitingFondazione Epatocentro Ticino102025-09-012026-08-21
Efficacy of Methylene Blue Plus Ropivacaine for Post-Hemorrhoidectomy Pain.
Methylene Blue (0.3%) with Ropivacaine Hydrochloride (0.75%), Methylene Blue (0.1%) with Ropivacaine Hydrochloride (0.75%) - Mixed Hemorrhoids, Milligan-Morgan Hemorrhoidectomy
Phase 4Not yet recruitingThe Affiliated Hospital of Putian University1772025-08-302025-09-10
Local Injection Methylene Blue Combined With Radiation in HNSCC Patients
Methylene Blue (50 mg/10ml) - Head and Neck Cancer, Local Recurrent Tumor
Early Phase 1Active not recruitingChina Medical University Hospital102025-08-012026-02-27
Hemodynamic Effects of Intradermal Methylene Blue During Breast Surgery Under General Anesthesia
Methylene Blue, Standard Surgical Care Without Dye - Breast Cancer, Breast Surgery
CompletedDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital2202025-07-012026-04-30
Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
Methylene Blue - Cytokine Release Syndrome, ICANS
Phase 1RecruitingInstitute of Hematology & Blood Diseases Hospital, China182025-06-282025-09-11
Adjunctive Methylene Blue in Septic Shock
Methylene Blue, Usual Care - Septic Shock
Phase 3CompletedDr. Shannon M. Fernando502025-06-022026-03-19
The Effect of Methylene Blue Infiltrating Injection on Anal Pain After Milligan-Morgan Surgery: A Randomized Controlled Clinical Study
Methylene Blue - Mixed Hemorrhoids
Phase 3Enrolling by invitationThe Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine602024-10-252024-10-28
Methylene Blue for the Treatment of Septic Shock
Methylene Blue, Placebo - Septic Shock
Phase 3CompletedNorthern Jiangsu People's Hospital882024-08-052026-02-04
Clinical and Microbiological Evaluation of Laser Therapy in the Treatment of Periodontal Disease in Stages III and IV
Antimicrobial photodynamic therapy and 0.005% methylene blue (PDT), Photobiomodulation with a red laser (PBM-RL), Saline solution - Periodontitis, Periodontitis, Adult
Not applicableCompletedUniversidade Federal Fluminense202024-05-062026-02-27
Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock
Methylene Blue, Placebo - Neonatal Sepsis, Shock, Septic
Phase 2 / Phase 3Not yet recruitingPost Graduate Institute of Medical Education and Research, Chandigarh1302024-03-152024-03-12
A Study of Ropivacaine Combined With Different Concentrations of Methylene Blue Fascia Iliaca Block in Postoperative Analgesia, Cognition, and Hip Function Recovery in Patients Undergoing Hip Arthroplasty
Ropivacaine combined with methylene blue for iliac fascia block - Femoral Neck Disease
Not applicableUnknownWang wanxia752024-03-152024-07-25
Low Dose Versus High Dose Methylene Blue in Septic Patients
Normal saline, Methylene Blue low dose, Methylene Blue high dose - Septic Shock
Phase 2 / Phase 3CompletedNational Cancer Institute, Egypt902023-08-012024-07-05
A Study of Ropivacaine Complex Methylene Blue Fascia Iliaca Compartment Block on Analgesia in Patients Undergoing Hip Arthroplasty
Ropivacaine combined with methylene blue for iliac fascia block - Femoral Neck Disease
Not applicableCompletedWang wanxia902023-06-202025-02-04
A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.
Sentinel lymph node identification, indocyanine green, methylene blue - Breast Cancer
CompletedBTG International Inc.1012023-06-062024-05-10

Showing 20 of 95. Sign in to see all of them.

Conditions studied

Shock, Septic (12)  ·  Breast Neoplasms (7)  ·  Shock (5)  ·  COVID-19 (4)  ·  Periodontal Diseases (3)  ·  Sepsis (3)  ·  Vasoplegia (3)  ·  Abscess (2)  ·  Chronic Periodontitis (2)  ·  Emergence Delirium (2)  ·  Malaria (2)  ·  Methemoglobinemia (2)  ·  Neonatal Sepsis (2)  ·  Neoplasms (2)  ·  Periodontal Pocket (2)

Sponsors

Heidelberg University (3)  ·  University of Rochester (3)  ·  Ain Shams University (2)  ·  Chinese Academy of Sciences (2)  ·  Chulalongkorn University (2)  ·  Fondazione Epatocentro Ticino (2)  ·  Fudan University (2)  ·  Mashhad University of Medical Sciences (2)  ·  The University of Texas Health Science Center at San Antonio (2)  ·  University of Nove de Julho (2)  ·  University of Oxford (2)  ·  Wang wanxia (2)  ·  Affiliated Hospital to Academy of Military Medical Sciences (1)  ·  Alexandria University (1)  ·  American Regent, Inc. (1)

Countries

United States (22)  ·  China (17)  ·  Brazil (7)  ·  Egypt (5)  ·  France (4)  ·  Iran (4)  ·  Thailand (4)  ·  Burkina Faso (3)  ·  Canada (3)  ·  Russia (3)  ·  Switzerland (3)  ·  United Kingdom (3)  ·  India (2)  ·  Turkey (Türkiye) (2)  ·  Hungary (1)

Top investigators

Ashwani K Sharma, MD (2)  ·  Daryoush Hamidi Alamdari, Ph.D (2)  ·  Jun Zhang, PhD (2)  ·  Laurie Christensen, BS (2)  ·  Timothy M Baran, PhD (2)  ·  Adriana Miclescu (1)  ·  Ahmed Mukhtar, Professor (1)  ·  Alassane Dicko, MD (1)  ·  Alfonso Fiorelli, MD, PhD (1)  ·  Artem A. Shiryaev, Ph.D. (1)  ·  Ayman I Tharwat, MD (1)  ·  Balazs Banky, PhD (1)  ·  Boris Mraovic, MD (1)  ·  Bruno Megarbane (1)

Results publications

PMID 11588440, PMID 12500513, PMID 16134766, PMID 24358319, PMID 27497181, PMID 36915146, PMID 12519925, PMID 14759425, PMID 15267226, PMID 17698886, PMID 18286187, PMID 18477932, PMID 19415120, PMID 19846959, PMID 20093545, PMID 20109575, PMID 21246318, PMID 24151551, PMID 24316434, PMID 24350844, PMID 24814697, PMID 25267980, PMID 25410983, PMID 26683506, PMID 27284082, PMID 27673307, PMID 28576285, PMID 28593326, PMID 28686823, PMID 28723883, PMID 28840449, PMID 29151412, PMID 29290809, PMID 29422384, PMID 29508706, PMID 29936590, PMID 30231909, PMID 30859424, PMID 31027098, PMID 31600221, PMID 32270211, PMID 32453920, PMID 32520577, PMID 32828741, PMID 34019535, PMID 34719443, PMID 36237547, PMID 36324139, PMID 36505110, PMID 36705345

NIH funding

2017 (1), R34MH087375 (1), U10CA027469 (1)